Tag: Amicus Therapeutics Inc.

[breadcrumb_custom]

Company

Now Is A Good Time To Buy Amicus Therapeutics Inc (NASDAQ: FOLD)

During the last session, Amicus Therapeutics Inc (NASDAQ:FOLD)’s traded shares were 2.74 million, with the beta value of the company hitting 0.76. At the end

Science

Weak Fundamental Momentum Pushes Amicus Therapeutics Inc (FOLD) Lower

Amicus Therapeutics Inc (NASDAQ:FOLD) has a beta value of 0.76 and has seen 3.7 million shares traded in the last trading session. The company, currently

Business

Amicus Therapeutics Inc (NASDAQ: FOLD) Has Slid Negatively For The Year To Date, Predicting What Will Happen Next

Amicus Therapeutics Inc (NASDAQ:FOLD)’s traded shares stood at 3.6 million during the last session, with the company’s beta value hitting 0.76. At the close of

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: Amicus Therapeutics Inc.

Now Is A Good Time To Buy Amicus Therapeutics Inc (NASDAQ: FOLD)

Weak Fundamental Momentum Pushes Amicus Therapeutics Inc (FOLD) Lower

Amicus Therapeutics Inc (NASDAQ: FOLD) Has Slid Negatively For The Year To Date, Predicting What Will Happen Next

Categories

Quick links